Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10792345rdf:typepubmed:Citationlld:pubmed
pubmed-article:10792345lifeskim:mentionsumls-concept:C0012634lld:lifeskim
pubmed-article:10792345lifeskim:mentionsumls-concept:C0031809lld:lifeskim
pubmed-article:10792345lifeskim:mentionsumls-concept:C0339143lld:lifeskim
pubmed-article:10792345lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:10792345lifeskim:mentionsumls-concept:C0041618lld:lifeskim
pubmed-article:10792345lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:10792345lifeskim:mentionsumls-concept:C0549193lld:lifeskim
pubmed-article:10792345pubmed:issue5lld:pubmed
pubmed-article:10792345pubmed:dateCreated2000-8-1lld:pubmed
pubmed-article:10792345pubmed:abstractTextTo study if A-mode ultrasonography (US) in combination with the Clinical Activity Score (CAS) and duration of Graves' ophthalmopathy (GO) could predict the response to immunosuppression in Graves' ophthalmopathy.lld:pubmed
pubmed-article:10792345pubmed:languageenglld:pubmed
pubmed-article:10792345pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10792345pubmed:citationSubsetIMlld:pubmed
pubmed-article:10792345pubmed:statusMEDLINElld:pubmed
pubmed-article:10792345pubmed:monthMaylld:pubmed
pubmed-article:10792345pubmed:issn0300-0664lld:pubmed
pubmed-article:10792345pubmed:authorpubmed-author:WiersingaW...lld:pubmed
pubmed-article:10792345pubmed:authorpubmed-author:PrummelM FMFlld:pubmed
pubmed-article:10792345pubmed:authorpubmed-author:GerdingM NMNlld:pubmed
pubmed-article:10792345pubmed:issnTypePrintlld:pubmed
pubmed-article:10792345pubmed:volume52lld:pubmed
pubmed-article:10792345pubmed:ownerNLMlld:pubmed
pubmed-article:10792345pubmed:authorsCompleteYlld:pubmed
pubmed-article:10792345pubmed:pagination641-6lld:pubmed
pubmed-article:10792345pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10792345pubmed:meshHeadingpubmed-meshheading:10792345...lld:pubmed
pubmed-article:10792345pubmed:meshHeadingpubmed-meshheading:10792345...lld:pubmed
pubmed-article:10792345pubmed:meshHeadingpubmed-meshheading:10792345...lld:pubmed
pubmed-article:10792345pubmed:meshHeadingpubmed-meshheading:10792345...lld:pubmed
pubmed-article:10792345pubmed:meshHeadingpubmed-meshheading:10792345...lld:pubmed
pubmed-article:10792345pubmed:meshHeadingpubmed-meshheading:10792345...lld:pubmed
pubmed-article:10792345pubmed:meshHeadingpubmed-meshheading:10792345...lld:pubmed
pubmed-article:10792345pubmed:meshHeadingpubmed-meshheading:10792345...lld:pubmed
pubmed-article:10792345pubmed:meshHeadingpubmed-meshheading:10792345...lld:pubmed
pubmed-article:10792345pubmed:meshHeadingpubmed-meshheading:10792345...lld:pubmed
pubmed-article:10792345pubmed:meshHeadingpubmed-meshheading:10792345...lld:pubmed
pubmed-article:10792345pubmed:meshHeadingpubmed-meshheading:10792345...lld:pubmed
pubmed-article:10792345pubmed:year2000lld:pubmed
pubmed-article:10792345pubmed:articleTitleAssessment of disease activity in Graves' ophthalmopathy by orbital ultrasonography and clinical parameters.lld:pubmed
pubmed-article:10792345pubmed:affiliationDepartment of Endocrinology and Metabolism, and Orbital Center, Academic Medical Center, Amsterdam, The Netherlands.lld:pubmed
pubmed-article:10792345pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10792345pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed